Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederema.europa.eu
What's new
Get the latest updates from What's new directly as they happen.
Follow now 448 followers
Latest posts
Last updated about 12 hours ago
Human medicines European public assessment report (EPAR): mCombriax, influenza mRNA vaccine,COVID-19 mRNA vaccine, Date of authorisation: 20/04/2026, Revision: 1, Status: Authorised
about 12 hours ago
Human medicines European public assessment report (EPAR): mCombriax, influenza mRNA vaccine,COVID-19 mRNA...
Human medicines European public assessment report (EPAR): Pegasys, peginterferon alfa-2a, Date of authorisation: 20/06/2002, Revision: 49, Status: Authorised
about 13 hours ago
Human medicines European public assessment report (EPAR): Pegasys, peginterferon alfa-2a, Date of...
Human medicines European public assessment report (EPAR): Prevenar 13, pneumococcal polysaccharide conjugate vaccine (13-valent, adsorbed), Date of authorisation: 09/12/2009, Revision: 51, Status: Authorised
about 13 hours ago
Human medicines European public assessment report (EPAR): Prevenar 13, pneumococcal polysaccharide conjugate...
Human medicines European public assessment report (EPAR): Blincyto, blinatumomab, Date of authorisation: 23/11/2015, Revision: 26, Status: Authorised
about 13 hours ago
Human medicines European public assessment report (EPAR): Blincyto, blinatumomab, Date of authorisation...
Human medicines European public assessment report (EPAR): Xbonzy, denosumab, Date of authorisation: 17/11/2025, Revision: 3, Status: Authorised
about 13 hours ago
Human medicines European public assessment report (EPAR): Xbonzy, denosumab, Date of authorisation...
Human medicines European public assessment report (EPAR): Xarelto, rivaroxaban, Date of authorisation: 30/09/2008, Revision: 43, Status: Authorised
about 13 hours ago
Human medicines European public assessment report (EPAR): Xarelto, rivaroxaban, Date of authorisation...
Human medicines European public assessment report (EPAR): Leflunomide Zentiva (previously Leflunomide Winthrop), leflunomide, Date of authorisation: 08/01/2010, Revision: 24, Status: Authorised
about 13 hours ago
Human medicines European public assessment report (EPAR): Leflunomide Zentiva (previously Leflunomide Winthrop)...
Human medicines European public assessment report (EPAR): Icotyde, icotrokinra hydrochloride, Date of authorisation: 18/09/2026, Status: Authorised
about 13 hours ago
Human medicines European public assessment report (EPAR): Icotyde, icotrokinra hydrochloride, Date of...
Human medicines European public assessment report (EPAR): Zokovea, ensitrelvir, Date of authorisation: 18/09/2026, Status: Authorised
about 14 hours ago
Human medicines European public assessment report (EPAR): Zokovea, ensitrelvir, Date of authorisation...
Meeting of the Executive Steering Group on Shortages and Safety of Medicinal Products (MSSG) - September 2026, Online, European Medicines Agency, Amsterdam, the Netherlands, from 23 September 2026, 10:00 (CEST) to 23 September 2026, 12:00 (CEST)
about 4 hours ago
Meeting of the Executive Steering Group on Shortages and Safety of Medicinal...
Human medicines European public assessment report (EPAR): Tacquell, Autologous melanoma-derived tumor infiltrating lymphocytes, ex vivo-expanded, Date of refusal: 14/09/2026, Status: Refused
about 15 hours ago
Human medicines European public assessment report (EPAR): Tacquell, Autologous melanoma-derived tumor infiltrating...
CHMP opinions on consultation procedures on ancillary substances incorporated in a medical device
about 15 hours ago
CHMP opinions on consultation procedures on ancillary substances incorporated in a medical...